Searching across hundreds of databases

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Platelet-rich plasma-derived scaffolds increase the benefit of delayed mesenchymal stromal cell therapy after severe traumatic brain injury.

C Bonilla Horcajo | M Zurita Castillo | J Vaquero Crespo
Cytotherapy | 2018 Mar

Cell therapy using mesenchymal stromal cells (MSCs) offers new perspectives in the treatment of traumatic brain injury (TBI). The aim of the present study was to assess the impact of platelet-rich plasma scaffolds (PRPS) as support of MSCs in a delayed phase after severe TBI in rats.

Pubmed ID: 29306567

TBI Model

  • Weight-drop model
  • Animal Information

  • Species: rat
  • Strain: Wistar
  • Age (weeks): 13 - 13
  • Weight (grams): 200 - 250
  • Assessments

    Rotarod test, VTB test, degree of lesion, modified Neurological Severity Score (mNSS)

    TBI model parameters

  • Impact Depth (mm): No information available
  • Impact Duration (ms): No information available
  • Impact Velocity (m/s): No information available
  • Impactor Tip: No information available
  • Device Name

    No information available

    Associated Datasets

    No information available

    Associated Protocols

    No information available